Vaccine preparedness - Are we ready for the next influenza pandemic?

New England Journal of Medicine

Volumn 358, Issue 24, 2008, Pages 2540-2543

  Wright, Peter F ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; VIRUS VACCINE;

ANTIBODY RESPONSE; ANTIGENICITY; BIRD DISEASE; DNA MODIFICATION; FOOD AND DRUG ADMINISTRATION; HONG KONG; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS A H5N1; NONHUMAN; PANDEMIC; POLIOMYELITIS VIRUS; POULTRY; PRIORITY JOURNAL; SHORT SURVEY; VIRION; VIRUS VIRULENCE;

EID: 45149130345     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp0803650     Document Type: Article

References (2)

1. World Health Organization. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. April 17, 2008. (Accessed May 23, 2008, at http://www.who.int/csr/disease/avian_ influenza/country/ cases_table_2008_04_17/en/.)
2. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006;354:1343-51.